ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
176 |
43K |
9 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
176
|
43K
|
9
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Chimeric receives $1.5 M advance on FY24 R&D tax incentive
|
|
NZ Trader
|
40 |
8.3K |
7 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
40
|
8.3K
|
7
|
|
ASX - By Stock
|
BIT |
Re:
Complete headline results for Commercial Deal, when?
|
|
NZ Trader
|
230 |
55K |
1 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
230
|
55K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Complete headline results for Commercial Deal, when?
|
|
NZ Trader
|
230 |
55K |
0 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
230
|
55K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Chimeric receives $1.5 M advance on FY24 R&D tax incentive
|
|
NZ Trader
|
40 |
8.3K |
5 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
40
|
8.3K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
Complete headline results for Commercial Deal, when?
|
|
NZ Trader
|
230 |
55K |
12 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
230
|
55K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
NZ Trader
|
248 |
67K |
17 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
248
|
67K
|
17
|
|
ASX - By Stock
|
BIT |
Re:
Complete headline results for Commercial Deal, when?
|
|
NZ Trader
|
230 |
55K |
6 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
230
|
55K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
176 |
43K |
14 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
176
|
43K
|
14
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Chimeric partnering with Cell Therapies Australia
|
|
NZ Trader
|
16 |
4.2K |
6 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
16
|
4.2K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
Complete headline results for Commercial Deal, when?
|
|
NZ Trader
|
230 |
55K |
4 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
230
|
55K
|
4
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Phase 2 blood cancer trial fully recruited
|
|
NZ Trader
|
21 |
5.8K |
7 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
21
|
5.8K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
176 |
43K |
10 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
176
|
43K
|
10
|
|
ASX - By Stock
|
BIT |
Re:
Complete headline results for Commercial Deal, when?
|
|
NZ Trader
|
230 |
55K |
4 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
230
|
55K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
176 |
43K |
9 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
176
|
43K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
176 |
43K |
3 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
176
|
43K
|
3
|
|
ASX - By Stock
|
KRM |
Re:
KRM Chart
|
|
NZ Trader
|
1.5K |
349K |
1 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
1.5K
|
349K
|
1
|
|
ASX - By Stock
|
KRM |
Re:
KRM Chart
|
|
NZ Trader
|
1.5K |
349K |
1 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
1.5K
|
349K
|
1
|
|
ASX - By Stock
|
KRM |
Re:
Ann: Kingsrose Commences Drilling at Rana Project
|
|
NZ Trader
|
1 |
540 |
1 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
1
|
540
|
1
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Neurotech Global Partnering and Registration Strategy
|
|
NZ Trader
|
7 |
1.9K |
6 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
7
|
1.9K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
176 |
43K |
13 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
176
|
43K
|
13
|
|
ASX - By Stock
|
KRM |
Re:
KRM Chart
|
|
NZ Trader
|
1.5K |
349K |
2 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
1.5K
|
349K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Complete headline results for Commercial Deal, when?
|
|
NZ Trader
|
230 |
55K |
11 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
230
|
55K
|
11
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Phase 2 blood cancer trial fully recruited
|
|
NZ Trader
|
21 |
5.8K |
11 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
21
|
5.8K
|
11
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Chimeric partnering with Cell Therapies Australia
|
|
NZ Trader
|
16 |
4.2K |
4 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
16
|
4.2K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
176 |
43K |
16 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
176
|
43K
|
16
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
176 |
43K |
11 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
176
|
43K
|
11
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
176 |
43K |
6 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
176
|
43K
|
6
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Phase 2 blood cancer trial fully recruited
|
|
NZ Trader
|
21 |
5.8K |
14 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
21
|
5.8K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
176 |
43K |
16 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
176
|
43K
|
16
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
176 |
43K |
7 |
08/08/24 |
08/08/24 |
ASX - By Stock
|
176
|
43K
|
7
|
|
ASX - By Stock
|
SNT |
Re:
Ann: German MDS group awarded $2.5m grant for phase 2 MDS trial
|
|
NZ Trader
|
4 |
1.2K |
10 |
08/08/24 |
08/08/24 |
ASX - By Stock
|
4
|
1.2K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Latest MND Webinar information on Monepantel
|
|
NZ Trader
|
33 |
8.3K |
10 |
08/08/24 |
08/08/24 |
ASX - By Stock
|
33
|
8.3K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
176 |
43K |
12 |
08/08/24 |
08/08/24 |
ASX - By Stock
|
176
|
43K
|
12
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Phase 2 blood cancer trial fully recruited
|
|
NZ Trader
|
21 |
5.8K |
16 |
08/08/24 |
08/08/24 |
ASX - By Stock
|
21
|
5.8K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Latest MND Webinar information on Monepantel
|
|
NZ Trader
|
33 |
8.3K |
25 |
07/08/24 |
07/08/24 |
ASX - By Stock
|
33
|
8.3K
|
25
|
|
ASX - By Stock
|
SNT |
Re:
SNT - General Discussions
|
|
NZ Trader
|
117 |
30K |
6 |
07/08/24 |
07/08/24 |
ASX - By Stock
|
117
|
30K
|
6
|
|
ASX - By Stock
|
KRM |
Re:
Ann: KRM receives Exploration Permit for Drilling Penikat Project
|
|
NZ Trader
|
67 |
18K |
1 |
07/08/24 |
07/08/24 |
ASX - By Stock
|
67
|
18K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
NZ Trader
|
159 |
37K |
6 |
07/08/24 |
07/08/24 |
ASX - By Stock
|
159
|
37K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
176 |
43K |
16 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
176
|
43K
|
16
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Application for quotation of securities - CHM
|
|
NZ Trader
|
25 |
6.4K |
11 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
25
|
6.4K
|
11
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Phase 2 blood cancer trial fully recruited
|
|
NZ Trader
|
21 |
5.8K |
10 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
21
|
5.8K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
176 |
43K |
75 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
176
|
43K
|
75
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Application for quotation of securities - CHM
|
|
NZ Trader
|
25 |
6.4K |
8 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
25
|
6.4K
|
8
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
NZ Trader
|
73 |
15K |
1 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
73
|
15K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
NZ Trader
|
73 |
15K |
2 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
73
|
15K
|
2
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
16 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
978
|
265K
|
16
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Application for quotation of securities - CHM
|
|
NZ Trader
|
25 |
6.4K |
7 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
25
|
6.4K
|
7
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
NZ Trader
|
159 |
37K |
2 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
159
|
37K
|
2
|
|
ASX - By Stock
|
KRM |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
NZ Trader
|
22 |
5.5K |
2 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
22
|
5.5K
|
2
|
|